Plasmonic silver nanoshells for drug and metabolite detection
Preparation of samples for diagnosis can affect the detection of biomarkers and metabolites. Here, the authors use a silver nanoparticle plasmonics approach for the detection of biomarkers in patients as well as investigate the distribution of drugs in serum and cerebral spinal fluid.
Guardado en:
Autores principales: | Lin Huang, Jingjing Wan, Xiang Wei, Yu Liu, Jingyi Huang, Xuming Sun, Ru Zhang, Deepanjali D. Gurav, Vadanasundari Vedarethinam, Yan Li, Ruoping Chen, Kun Qian |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a92e3a1d876640c5b00846f49fee7c3b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ultrahigh sensitive refractive index nanosensors based on nanoshells, nanocages and nanoframes: effects of plasmon hybridization and restoring force
por: MirKazem Omrani, et al.
Publicado: (2021) -
Diagnosis and prognosis of myocardial infarction on a plasmonic chip
por: Wei Xu, et al.
Publicado: (2020) -
Plasmonic twinned silver nanoparticles with molecular precision
por: Huayan Yang, et al.
Publicado: (2016) -
Effect of intratumoral administration on biodistribution of 64Cu-labeled nanoshells
por: Xie H, et al.
Publicado: (2012) -
Polymer coated gold nanoshells for combinational photochemotherapy of pancreatic cancer with gemcitabine
por: Mina Emamzadeh, et al.
Publicado: (2021)